Venture Fund VII L. P. Atlas serves as Executive at ARCA biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Venture Fund VII L. P. Atlas has executed 7 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 11, 2014 involved purchasing 41,667 shares valued at $500.0K.
Venture Fund VII L. P. Atlas currently holds 2,152,222 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Fund VII L. P. Atlas has been a net seller of ABIO stock. They have purchased $500.0K and sold $1.1M worth of shares.
Venture Fund VII L. P. Atlas's most recent insider trade was on Feb 11, 2014, when they purchased 41,667 shares at $12.00 per share.
Get notified when new Form 4 filings are submitted
| $6.00 |
| Discretionary |
| Feb 11, 2014 | EGLT | $1.8M | Conversion | 298,083 | $6.00 | Discretionary |
| Feb 11, 2014 | EGLT | $0 | Exercise | 30,000 | $N/A | Discretionary |
| Feb 11, 2014 | EGLT | $0 | Conversion | 863,754 | $N/A | Discretionary |
| Feb 11, 2014 | EGLT | $0 | Conversion | 833,098 | $N/A | Discretionary |
| Mar 29, 2010 | ABIO | $1.1M | Sale | 140,000 | $7.56 | Discretionary |